Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect.
David GibsonAkshay RaviEduardo RodriguezSusan ChangNancy Oberheim BushJennie W TaylorJennifer L ClarkeDavid SolomonAaron SchefflerJohn WitteHannah LambingHideho OkadaMitchel BergerFarid ChehabNicholas A ButowskiPublished in: Neuro-oncology advances (2023)
and underlines the clinical importance of determining its prognostic utility. Potential limitations include censoring, sample size, and extraneous mutations.